IDEAYA Biosciences
Stock Forecast, Prediction & Price Target
IDEAYA Biosciences Financial Estimates
IDEAYA Biosciences Revenue Estimates
IDEAYA Biosciences EBITDA Estimates
IDEAYA Biosciences Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $27.94M N/A | $50.93M 82.28% | $23.38M -54.08% | Avg: $104.62M Low: $51.93M High: $199.00M avg. 347.41% | Avg: $87.32M Low: $41.41M High: $153.37M avg. -16.54% | Avg: $275.66M Low: $130.73M High: $484.18M avg. 215.69% | Avg: $679.43M Low: $322.21M High: $1.19B avg. 146.46% |
Net Income
% change YoY
| $-47.53M N/A | $-54.80M -15.31% | $-112.96M -106.10% | Avg: $-131.88M Low: $-182.91M High: $333.99M avg. -16.74% | Avg: $-170.21M Low: $-189.24M High: $-45.44M avg. -29.06% | Avg: $-33.21M Low: $-65.88M High: $-10.51M avg. 80.48% | Avg: $173.13M Low: $54.79M High: $343.38M avg. 621.21% |
EBITDA
% change YoY
| $-50.26M N/A | $-62.50M -24.33% | $-130.42M -108.66% | Avg: $-62.77M Low: $-119.40M High: $-31.15M avg. 51.86% | Avg: $-52.39M Low: $-92.02M High: $-24.84M avg. 16.54% | Avg: $-165.40M Low: $-290.51M High: $-78.44M avg. -215.69% | Avg: $-407.65M Low: $-716.01M High: $-193.32M avg. -146.46% |
EPS
% change YoY
| -$1.35 N/A | -$1.32 2.22% | -$1.96 -48.48% | Avg: -$1.8 Low: -$3.18 High: $5.81 avg. 8.08% | Avg: -$2.12 Low: -$3.29 High: -$0.79 avg. -17.44% | Avg: -$0.58 Low: -$1.15 High: -$0.18 avg. 72.70% | Avg: $3.01 Low: $0.95 High: $5.97 avg. 621.21% |
Operating Expenses
% change YoY
| $78.20M N/A | $113.43M 45.03% | $157.81M 39.12% | Avg: $87.35M Low: $43.35M High: $166.14M avg. -44.64% | Avg: $72.90M Low: $34.57M High: $128.04M avg. -16.54% | Avg: $230.15M Low: $109.14M High: $404.24M avg. 215.69% | Avg: $567.24M Low: $269.01M High: $996.31M avg. 146.46% |
FAQ
What is IDEAYA Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 163.97% in 2025-2028.
We have gathered data from 9 analysts. Their low estimate is -182.91M, average is -131.88M and high is 333.99M.
What is IDEAYA Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 173.25% in 2025-2028.
We have gathered data from 7 analysts. Their low revenue estimate is $51.93M, average is $104.62M and high is $199.00M.
What is IDEAYA Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 171.14% in 2025-2028.
We have gathered data from 9 analysts. Their low earnings per share estimate is -$3.18, average is -$1.8 and high is $5.80.
What is the best performing analyst?
In the last twelve months analysts have been covering IDEAYA Biosciences stock. The most successful analyst is Andrew Berens.